ACAP’s inventory of compensable cases include medical records and nurse reviews, as well as everything your firm needs to settle or take to trial. Choose the cases you want, based on specific attributes and case strength matrix.

Our current inventory of compensable cases includes:


Over 1,200 lawsuits are pending in federal courts and over 18,000 plaintiffs are suing Monsanto, claiming the weed killer caused plaintiffs to develop non-Hodgkin’s lymphoma and other cancers. The World Health Organization has determined glyphosate, the active ingredient in Roundup, is “probably carcinogenic to humans.”

Talcum Powder

Johnson & Johnson faces roughly 14,000 lawsuits over allegations its talcum powder products caused ovarian cancer and mesothelioma and that the company concealed its products were sometimes tainted with asbestos. Federal lawsuits have been centralized as a multidistrict litigation (MDL) in New Jersey. Numerous cases are also pending in state courts.

3M Earplugs

3M Company and its subsidiary Aearo Technologies face over 2,000 lawsuits in a Florida federal court for the companies’ dual-ended Combat Arms earplugs, which were standard issue in certain branches of military between 2003-2015. A design defect concealed by the companies placed soldiers at risk for significant hearing loss and tinnitus.

Hernia Mesh

Over 6,800 hernia mesh lawsuits are pending in 3 separate multidistrict litigations (MDLs) against manufacturers Bard Davol, Ethicon, and Atrium. Hernia mesh lawsuits claim the devices have caused infections, perforation, adhesions, and other serious injuries, as well as wrongful death. Patients may be required to have revision surgery, as well.


Lawsuits against Gilead Sciences allege the company intentionally withheld a safer version of Truvada. The HIV drug marketed by Gilead Sciences, Truvada contains tenofovir (TDF), a drug linked to severe side effects, including kidney failure, osteoporosis, and broken bones.


A widespread recall of at least 75 blood pressure prompted lawsuits throughout the country, which were consolidated in a New Jersey federal court. The generic versions of drugs containing Valsartan and other angiotensin II blockers were found to be tainted or contaminated with NDMA, a probable carcinogen that is also toxic to the liver.


Lawsuits filed throughout the country claim JUUL Labs and its owner Altria (formerly Phillip Morris) engaged in a false and deceptive marketing campaign directed at teens. Plaintiffs also include parents of minors who became addicted to nicotine in JUUL pods. Additional lawsuits filed allege injuries from JUUL vaping products, including pulmonary disease and seizures.